These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17130255)

  • 21. Target organ protection from a novel angiotensin II receptor (AT1) vaccine ATR12181 in spontaneously hypertensive rats.
    Zhu F; Liao YH; Li LD; Cheng M; Wei F; Wei YM; Wang M
    Cell Mol Immunol; 2006 Apr; 3(2):107-14. PubMed ID: 16696897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
    Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy.
    Ebensperger R; Acevedo E; Meléndez J; Corbalán R; Acevedo M; Sapag-Hagar M; Jalil JE; Lavandero S
    Biochem Biophys Res Commun; 1998 Feb; 243(1):20-4. PubMed ID: 9473472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats.
    Meng C; Jin X; Xia L; Shen SM; Wang XL; Cai J; Chen GQ; Wang LS; Fang NY
    J Proteome Res; 2009 May; 8(5):2463-75. PubMed ID: 19265432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of left ventricular hypertrophy with different classes of drugs causes differing ventricular biochemical changes.
    Arita M; Horinaka S; Komatsu K; Frohlich ED
    J Hypertens Suppl; 1993 Dec; 11(5):S354-5. PubMed ID: 7512640
    [No Abstract]   [Full Text] [Related]  

  • 28. Relation between QRS amplitude and left ventricular mass in the initial stage of exercise-induced left ventricular hypertrophy in rats.
    Bacharova L; Michalak K; Kyselovic J; Klimas J
    Clin Exp Hypertens; 2005 Aug; 27(6):533-41. PubMed ID: 16081345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine.
    Duguay D; Pesant S; Deschepper CF; deBlois D
    J Hypertens; 2007 Jun; 25(6):1291-9. PubMed ID: 17563544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels.
    Lee CK; Han JS; Won KJ; Jung SH; Park HJ; Lee HM; Kim J; Park YS; Kim HJ; Park PJ; Park TK; Kim B
    Proteomics; 2009 Nov; 9(21):4851-8. PubMed ID: 19743417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression.
    Sorriento D; Santulli G; Fusco A; Anastasio A; Trimarco B; Iaccarino G
    Hypertension; 2010 Oct; 56(4):696-704. PubMed ID: 20660817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway.
    Ghosh J; Das J; Manna P; Sil PC
    Toxicol Appl Pharmacol; 2009 Oct; 240(1):73-87. PubMed ID: 19616567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPC1, CaN and NFATC3 signaling pathway in the pathogenesis and progression of left ventricular hypertrophy in spontaneously hypertensive rats.
    Zou G; Hong H; Lin X; Shi X; Wu Y; Chen L
    Clin Exp Hypertens; 2015; 37(3):223-34. PubMed ID: 25271479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
    Kato N; Liang YQ; Ochiai Y; Jesmin S
    Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of alpha-enolase in the normal and pathological cardiac growth.
    Zhu LA; Fang NY; Gao PJ; Jin X; Wang HY
    Exp Mol Pathol; 2009 Aug; 87(1):27-31. PubMed ID: 19450578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.